STRATA Skin Sciences, Inc.
SSKN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $7 | $5 | $13 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5 | $4 | $4 | $3 |
| Inventory | $2 | $3 | $6 | $3 |
| Other Curr. Assets | $2 | $2 | $2 | $0 |
| Total Curr. Assets | $17 | $16 | $18 | $20 |
| Property Plant & Equip (Net) | $11 | $12 | $8 | $8 |
| Goodwill | $3 | $7 | $9 | $9 |
| Intangibles | $5 | $7 | $17 | $10 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $20 | $26 | $35 | $27 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $36 | $42 | $52 | $47 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $3 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $6 | $4 | $4 | $4 |
| Deferred Revenue | $2 | $2 | $3 | $3 |
| Other Curr. Liab. | $3 | $2 | $3 | $3 |
| Total Curr. Liab. | $15 | $12 | $13 | $13 |
| LT Debt | $16 | $15 | $8 | $8 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $2 | $8 | $0 |
| Total NC Liab. | $17 | $17 | $17 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $31 | $29 | $30 | $21 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$248 | -$238 | -$227 | -$222 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $253 | $251 | $249 | $247 |
| Total Equity | $5 | $13 | $22 | $25 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $36 | $42 | $52 | $47 |
| Net Debt | $9 | $9 | $3 | -$5 |